Gilead upgraded to outperform by Leerink on PrEP outlook
Leerink has upgraded Gilead Sciences (GILD) to outperform, citing the growth outlook for its PrEP medication lenacapavir for ...
Global Antibody-Drug Conjugate Market Set for a ~USD 26 Billion Surge by 2030 | DelveInsight
DelveInsight's Antibody-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...
PharmiWeb9h
Cell and Gene Therapy Clinical Trial Market is expected to reach USD 119.3 Billion by 2032 at a 24.9% of CAGR
With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, ...
Renal & Urology News8h
Trodelvy US Indication for Metastatic Urothelial Cancer to Be Withdrawn
Gilead is withdrawing the accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for metastatic urothelial cancer.
Antibody-Drug Conjugates Market to Grow at 28.4% CAGR from 2024 to 2029
PRNewswire/ -- "According to the latest BCC Research study, "The global ADCs market is showing a rapid growth trend, with growth rates of 36.5% and 40.7% ...
Yahoo Finance7h
Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight
New York, USA, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Allogeneic Hematopoietic Stem Cell Transplant Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight DelveInsight’s Allogeneic ...
Weather Underground18h
Mount Gilead, NC Weather Conditions
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.